Notification by WinMedica of benefits in accordance with the provisions of Article 66 paragraph 7a of law 4316/2014, the Publication Code of SFEE and the Publication Code of EFPIA.

According to article 66 paragraph 7a of Law 4316/2014, the pharmaceutical companies in Greece are obliged to disclose, according to the above provisions, on an individual basis per recipient each benefit granted to Health Professionals (HE) and Scientific Health Institutions (SCS) . In addition, the Publication Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Publication Code of the Association of Pharmaceutical Companies of Greece (SFEE) require their members to notify the payments and benefits to Health Professionals and Health Professionals.

On this page are published in a collective way the benefits of WinMedica to Health Professionals (HE) and individually the corresponding benefits to Scientific Health Institutions (SCS) for the period from 01/01/2015 – 31/12/2015.

We explicitly note that this disclosure was made after the issuance of no. 5/2016 Opinion of the Personal Data Protection Authority, the content of which we became aware only today 30.6.2016. We reserve the right to update the publication pending the final instructions of the involved bodies of the Management.

In any case, this disclosure is intended to enhance transparency in the relationship of pharmaceutical companies with EYs and EYFs as well as to protect patients’ right to know the relationship of pharmaceutical companies with the scientific community.

You can download the publication of WinMedica A.E. for 2015 from here.